• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing
  3. / Energy

Beware of 'Earnings Torpedos'

Some of the market's favorite stocks have entered a danger zone.
By TIM MELVIN Sep 23, 2013 | 02:00 PM EDT
Stocks quotes in this article: ARP, ATLS, CQP, EROC, ARIA, VVUS, IDIX, CRM, Z

We had split duties at Chez Melvin this weekend. The wife dedicated her time to seeing how much fall and Halloween decor she could get into the yard (she is the reason the displays are out so early), and I did research while watching sports. Although I had the disappointment of the Orioles playing themselves out of contention for the wild card in the American League, I did make some interesting discoveries that might help us make some money in the stock market, and the Ravens won rather convincingly.

As I have mentioned, I am something of a geek. Once I finished running stock screens and checking the stocks in my portfolio for any important fundamental changes, I surfed business-school websites for new papers or research articles that might contain significant information to help us as investors

I found a few of interest and will report back on them after I have digested them, but at the University of Michigan Ross School of Business site, I found something that interested me greatly and should interest you as well. The school is running two portfolios that are posted on its website. One includes stocks that are undervalued, and another one lists what the school calls "earnings torpedoes."

Earnings torpedoes are stocks that the students have identified as having the potential to blow up as a result of poor earnings. They use factors such as earnings quality, cash flows, momentum and valuation to identify stocks that could sink your portfolio. I checked through the historical lists the school keeps on the site, and the theory actually works very well at finding potential disasters and torpedoes that cause these stocks to underperform the market much of the time. I am cautious about the markets, and sometimes the best way to make money is to lose it, so the list is worth a review to see where danger may lurk.

The list is littered with energy-related master limited partnerships (MLPs). Many of these oil-and-gas-collection, transmission and storage partnerships have been bid up to very high levels as a result of strong oil prices and indiscriminate yield-seeking by investors. Billions of dollars have flooded into the sector as exchange-traded funds were formed to take advantage of the higher yields offered by these vehicles. Some of the better-known MLPs that are potential torpedo stocks are Atlas Resource Partners (ARP), Atlas Energy (ATLS), Cheniere Energy Partners (CQP) and Eagle Rock Energy Partners (EROC). Investors who own these names may want to review their holdings and consider lightening up on the shares.

The list is absolutely dominated by small-cap biotech stocks. Fifty percent of the list consists of biotechs such as Ariad Pharmaceuticals (ARIA), Vivus (VVUS) and Idenix Pharmaceuticals (IDIX). Biotech has been red hot this year -- the industry indices and ETFs are up more than 30% -- but investors might want to take some money off the table. I have long maintained that this is an incredibly specialized field, and if you don't possess, or have an adviser who possesses, a medical degree with a biotech concentration, small biotechs are dangerous for individual investors. Using ordinary fundamental or technical analysis techniques on these stocks is like playing financial Russian roulette, in my opinion. If you own individual small biotech stocks, it is worth your time to go the school's website and see if you are hanging on to a potential torpedo stock.

There are some big market darlings on the list that momentum investors need to be aware of before you take a torpedo amidships to your net worth. Salesforce.com (CRM) has shown up on several of my lists of red-flag stocks in recent weeks, even as the stock has run higher in recent weeks. Since it has a forward earnings estimate multiple of 100x, the slightest disappointment from this company is going to cause an implosion in the share price, and all but the most nimble of traders should probably avoid the stock at this level

Zillow (Z) is another trader favorite that has had a nice run as housing markets have recovered somewhat, but it is now on the danger list. At more than 150x estimated profits, it would not take much bad news to explode the stock and your portfolio along with it.

It is worth your time to check out the torpedo list on the University of Michigan site. Even if you decide you do not agree with them on certain stocks or sectors it is thought provoking and educational. Tomorrow I will take a look at the stocks the students have identified as undervalued and see if we can find any potential gems to buy.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Melvin had no positions in stocks mentioned.

TAGS: Investing | U.S. Equity | Healthcare | Energy | Technology

More from Energy

Here's How Investors Can Get in on Soaring Uranium Prices

Bruce Kamich
Jun 1, 2023 12:33 PM EDT

The charts of this fund are giving off a positive glow.

It's a Long Shot, but Here's My Ideal Scenario to Keep the Fed in Check

Bob Byrne
May 30, 2023 7:15 AM EDT

It involves people pocketing their savings from lower gasoline prices so that the economy cools and the Fed doesn't need to raise rates again.

3 High-Yield International Oil & Gas Majors

Bob Ciura
May 27, 2023 7:15 AM EDT

The top global energy names are returning more cash to shareholders through dividends and share repurchases.

CorEnergy Takes Important Step in Deleveraging

Jim Collins
May 25, 2023 1:15 PM EDT

However, the preferreds are no longer 'money good.' So a completely new 'distressed company' calculus has taken over.

Chevron: Drilling Down on the Charts

Bruce Kamich
May 23, 2023 2:18 PM EDT

Here's where aggressive traders could probe.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 01:51 PM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    Adjusting Your Trading Approach to Shifting Market...
  • 06:54 PM EDT CHRIS VERSACE

    AAP Podcast: A Tongue -- and a Market -- Twister: 'Get a Debt Deal Done'

    Listen in as the Action Alerts PLUS Podcast tackle...
  • 12:07 PM EDT STEPHEN GUILFOYLE

    Selling Some of This Surging AI-Related Stock

    This isn't the only name in the Stocks Under $10 p...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login